AssetMark Inc’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.6K Buy
146
+4
+3% +$288 ﹤0.01% 2483
2026
Q2
$10K Sell
142
-998
-88% -$53.9K ﹤0.01% 2448
2026
Q1
$59.6K Sell
1,140
-399
-26% -$24K ﹤0.01% 1692
2025
Q4
$90.5K Buy
1,539
+3
+0.2% +$182 ﹤0.01% 1528
2025
Q3
$85.5K Buy
1,536
+135
+10% +$7.23K ﹤0.01% 1482
2025
Q2
$72.1K Buy
1,401
+1,286
+1,118% +$64.6K ﹤0.01% 1443
2025
Q1
$6.74K Sell
115
-129
-53% -$8.74K ﹤0.01% 1926
2024
Q4
$17.6K Buy
244
+174
+249% +$12.8K ﹤0.01% 1686
2024
Q3
$5.6K Sell
70
-30
-30% -$2.25K ﹤0.01% 1718
2024
Q2
$7.16K Buy
+100
New +$7.36K ﹤0.01% 1552
2024
Q1
– Sell
-10
Closed -$772 – 2113
2023
Q4
$772 Buy
+10
New +$659 ﹤0.01% 1648
2022
Q1
– Sell
-8
Closed -$1K – 1741
2021
Q4
$1K Hold
8
– – ﹤0.01% 1473
2021
Q3
$1K Buy
+8
New +$974 ﹤0.01% 1358
2021
Q2
– Sell
-8
Closed -$1K – 1534
2021
Q1
$1K Buy
+8
New +$730 ﹤0.01% 1298
2018
Q1
– Sell
-28
Closed -$1K – 1960
2017
Q4
$1K Buy
+28
New +$890 ﹤0.01% 1717
2017
Q1
– Sell
-8
Closed – – 1436
2016
Q4
$0 Buy
+8
New +$210 ﹤0.01% 1390

Other funds holding TECH

AssetMark Inc's TECH Position: Q3 2026 in Review

AssetMark Inc increased its Bio-Techne (TECH) stake by 2.8% in Q3 2026, buying an estimated $288 and bringing the position to 146 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2483.

AssetMark Inc first reported a position in TECH in Q4 2016 and has held it in 16 quarters since. The position peaked at $90.5K in Q4 2025. 231 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • AssetMark Inc held 146 shares of Bio-Techne worth $10.6K as of Q3 2026.
  • AssetMark Inc bought 4 Bio-Techne shares in Q3 2026, an estimated $288.
  • Bio-Techne made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #2483 holding.
  • AssetMark Inc first reported a position in Bio-Techne in Q4 2016 and has held it in 16 quarters since.
  • AssetMark Inc's Bio-Techne position peaked at $90.5K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.